Explore ›
Finding
Finding
decline
In MarketScan data, women with HIV and non-dolutegravir antiretroviral exposure had significantly higher stillbirth risk compared to women without HIV, with an adjusted risk ratio of 2.10; no significant difference was observed in Medicaid data.
| Effect size | aRR 2.10 |
| CI | 95% CI 1.24-3.55 |
| Comparator | Women without HIV (stillbirth rate 58.8 per 10000 in MarketScan, 56.2 per 10000 in Medicaid) |
| Effect summary | decline; aRR 2.10; CI: 95% CI 1.24-3.55 |
Connected entities
Interventions
Conditions
Outcomes
Populations
Source
PMC10614030
Dolutegravir and pregnancy outcomes including neural tube defects in the USA during 2008–20: a national cohort study